Andrew McDonald is cofounder of LifeSci Index Partners and coportfolio Manager of BioShares funds. He is an experienced healthcare investment professional with experience in identifying transformative products and technologies in all stages of development. Prior to cofounding LifeSci Advisors, McDonald served as senior biotechnology analyst at Great Point Partners, a dedicated life science hedge fund. From 2004-2006, he was head of healthcare research and a biotechnology analyst at ThinkEquity Partners, a boutique investment bank. Prior to entering the financial services industry, he was a medicinal chemist at Cytokinetics, where he discovered and developed a promising anti-cancer agent. McDonald began his pharmaceutical career as a medicinal chemist at Pfizer. He received a Ph.D. in organic chemistry from UC Irvine and completed his bachelor's degree in chemistry at UC Berkeley.